Keywords: breast cancer, ferrocifen, indene metabolites, P450-dependent oxidation, quinone methides Ferrociphenols have been found to have high antiproliferative activity against estrogenindependent breast cancer cells. The rat and human liver microsome-mediated metabolism of three compounds of the ferrocifen (FC) family, 1,1-bis(4-hydroxy-phenyl)-2-ferrocenylbut-1-ene (FC1), 1-(4-hydroxyphenyl)-1-(phenyl)-2-ferrocenyl-but-1-ene (FC2), and 1-[4-(3-dimethylaminopropoxy)phenyl]-1-(4-hydroxyphenyl)-2-ferrocenyl-but-1-ene (FC3), was studied.
Introduction
Bioorganometallic chemistry is a field of research that encompasses organometallic compounds in biology and medicine. Following the initial appearance of this term in 1985, 1 this field gradually became a hotbed of research into new applications of organometallics, particularly in therapy and diagnostics. [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] We have shown that some ferrocene derivatives are very active against cancer cells. The addition of a ferrocenyl moiety to selected polyaromatic phenols, [13] [14] [15] [16] amines, 17, 18 amides, 19 and esters 19, 20 can potentiate their antiproliferative effects against breast and prostate cancer cells. For example, 4-hydroxytamoxifen, the active metabolite of the breast cancer drug tamoxifen, 21 shows limited cytotoxicity against hormone-refractory breast cancer cells (LC 50 for MDA-MB-231 cells:
29 µM). 22 However, the ferrociphenol FC3 (Figure 1 ), resulting from replacement of a phenyl group of hydroxytamoxifen with a ferrocenyl moiety, displays a dramatic improvement in cytotoxicity toward MDA-MB-231 cells (IC 50 = 0.5µM). 14 Ferrociphenols (FCs, Figure 1 ) are easily oxidized at relatively low redox potentials, with formation of the corresponding quinone methides (QMs, Figure 1 ), 23, 24 and it was recently shown that these reactive compounds are formed as a result of FC metabolism by liver microsomes, 25 and could play a role in the antitumor properties of FCs. The aim of the work described herein was to study the metabolism of FCs by liver microsomes to determine whether some metabolites are cytotoxic toward MDA-MB-231 breast cancer cells, and, in a more general manner, to potentially find new molecules that are cytotoxic toward hormone-independent breast cancer cells. This article describes a study of the metabolism of three ferrociphenols FC(1-3) by liver microsomes, a characterization of their metabolites, and a comparison between the cytotoxicities of these metabolites against breast cancer cells and those of the parent compounds. Three main classes of metabolites are formed: 1) the corresponding quinone methides QM(1-3) as described above, 2) allylic alcohols derived from hydroxylation of the ferrociphenols at the allylic position, and 3) indene derivatives that result from an intramolecular cyclization of the quinone methides.
Some of the new FCs obtained in this study show remarkable cytotoxic effects-even greater than those of their parent compounds-toward hormone-independent breast cancer cells.
Results and Discussion

Microsomal oxidation of FC1
An HPLC-MS study of incubations of FC1 at 200 µM with liver microsomes from phenobarbital-pretreated rats in the presence of an NADPH-generating system for 30 min (conditions given in the Experimental Section below) showed the formation of three main metabolites in equivalent amounts. Those metabolites were not formed under identical incubations in the absence of NADPH. One of them exhibited UV/Vis ( max = 414 nm) and MS (molecular ion at m/z = 423) characteristics identical to those previously reported for the quinone methide QM1 resulting from a two-electron oxidation of FC1 (Table 1) . 25 The second metabolite exhibited a UV/Vis spectrum similar to that of FC1 ( max = 237
with a shoulder at 290 nm, Figure 2A and Table 1 value of the spectra observed in HPLC-UV/Vis (see Experimental Section); for some compounds a clear shoulder was observed, the position of which is indicated in parentheses.
[e] Not determined.
We tried to synthesize authentic samples of those two alcohols ( Figure 3 ).
Unfortunately, our attempts to obtain AA1 failed. Only the primary alcohol PA1 was obtained from reduction of the related ethyl ester EE 27 by lithium aluminum hydride (Scheme 1).
The structure of PA1 was determined by X-ray crystallographic analysis. Figure 4 shows the ORTEP diagram of the structure of PA1; crystallographic data are given in the Supporting Information, and selected bond distances and bond angles are summarized in the figure legend. The structure shows that the ferrocenyl group is oriented as far as possible from the aryl ring, thus avoiding potential steric clash with this group.
The retention time and spectral characteristics of PA1 were clearly different from those of the alcohol metabolite, suggesting this metabolite to be the allylic alcohol AA1
( Figure 3 ). This is in agreement with the much greater reactivity that should be expected for the allylic position of FC1 toward metabolic oxidation, and with the fact that one of the metabolites resulting from microsomal oxidation of tamoxifen is an allylic alcohol. The third metabolite of FC1 exhibited a UV/Vis spectrum quite different from those of FC1 and of the two other metabolites, with  max at 323 nm ( Figure 5 A and Table   1 ). It was found to be formed when an authentic sample of QM1 was submitted to a protic medium (H 2 O or acetic acid used in the HPLC-MS studies). Indeed, this is described in the following section, as such an acid-catalyzed transformation was generally observed with all the quinone methides that we have previously obtained by oxidation of ferrociphenols. 
Acid-catalyzed cyclization of ferrociphenols to indene derivatives
In the presence of H 2 O or acetic acid, quinone methides QM1, QM2, and QM3 ( Figure 1) were progressively transformed into compounds exhibiting  max ~ 320 nm (Table 1) . Upon reaction of solutions of these quinone methides in dichloromethane with 3 equivalents of zinc(II) chloride, their conversion into cyclic compounds CP1, CP2, and CP3 was complete (Scheme 2). These cyclized products, CP, should derive from a protonation of the oxygen atom of the quinone methide function followed by an electrophilic attack of the resulting allylic cation on the phenol ring, as shown in Scheme 2. The formation of such indene products from the cyclization of an allylic cation derived from the allylic alcohol of tamoxifen was previously reported. 33 This type of indene was also observed in the ruthenocifen series, 34 analogues of the ferrocifen series. In 1 H NMR spectra, these cyclic compounds are characterized by the presence of a doublet at ~ 1.50 ppm corresponding to their methyl group and a quadruplet at ~ 3.70 ppm corresponding to the CH group of their C5 ring. In the case of CP2 and CP3, two isomers could be formed with respect to the two different arene rings on the molecule ( Figure 6 ).
However, acid-catalyzed cyclization of QM2 only led to isomer CP2a in 74 % yield.
Attachment of the CHCH 3 group to the phenol ring was confirmed by HMBC NMR experiments, which showed coupling signals between H1/C8, and CH 3 /C8. Other 1 H and 13 C NMR, MS, and UV/Vis characteristics were in complete agreement with the indene structure. In the case of CP3, the two isomers CP3a and CP3b were isolated in 64 % yield at a ratio of 7:3. The structure of the major isomer CP3a was identified by considering that its 1 H and 13 C NMR chemical shift values are closer to those of CP2a than those of CP3b. Interestingly, in the context of the following metabolic studies, some spectral characteristics allowed us to easily distinguish QM and CP metabolites (Tables 1 and 2 ).
The UV/Vis spectra of the latter are significantly blue-shifted relative to the former ( max ~ 320 instead of ~ 400 nm Notably, quinone methide QM2 was only detected as a very minor product in microsomal incubations of FC2. In fact, HPLC-MS studies of QM2 solutions in CH 3 CN/H 2 O mixtures showed its almost complete transformation into CP2.
Microsomal oxidation of FC3
Microsomal incubation of FC3 under conditions identical to those used for FC1 and FC2
led to five main metabolites (Scheme 3). Three of them were derived from reactions that were previously observed for FC1 and FC2 : QM3 and CP3 (a and b) ( Table 1 ) that were completely characterized by comparison of their HPLC retention times and UV/Vis and MS characteristics with those of authentic samples (QM3 was described previously 25 and CP3
was prepared as shown in Scheme 2), and a compound which could be the allylic alcohol (Table 1) . Its UV/Vis spectrum ( max = 232 nm with a shoulder at 287 nm, Table 1 ) was similar to that previously observed for allylic alcohol AA1.
Its MS 2 spectrum showed a major fragment at m/z = 508 (loss of H 2 O) and a minor fragment at m/z = 242 that could result from the loss of the C(para-OH-C 6 H 4 )(para-R-C 6 H 4 ) moiety after cleavage of the C=C bond. These data are in favor of structure AA3 for this metabolite. This structure is very likely if one compares these data to those obtained above for microsomal metabolism of FC1 and FC2, and because of the great reactivity of the allylic positions of FC derivatives. The retention time and MS and MS 2 spectra of DesMeFC3 were identical to those of the metabolite.
Compounds FC2 and FC3 are present as a mixture of two stereoisomers with Z or E configuration at the double bond. 15 Thus, their HPLC chromatogram exhibited two peaks of nearly equal intensity. Some of their microsomal metabolites, such as AA2, AA3, and DesMeFC3, also exhibited two more or less well-separated peaks that should correspond to their Z and E stereoisomers.
Oxidation of FC1 by human liver microsomes and recombinant human P450s
Incubations of FC1, FC2, and FC3 with human liver microsomes under identical conditions led to very similar results with the formation of the same major metabolites. As all the metabolites described above derived from oxidation reactions that were almost completely inhibited by N-benzylimidazole, a typical inhibitor of cytochromes P450, 35 we also studied the ability of human recombinant P450s to catalyze these reactions.
Experiments with commercially available microsomes of insect cells expressing P450 1A2, 2A6, 2B6, 2C8, 2C9, 2C19, 2D6, 2E1, and 3A4 showed P450s 2B6 and 3A4 to be the most active for the oxidation of FC1 into QM1, CP1, and AA1, with an activity of 8. Table 3 compares the IC 50 values measured for these FCs with those of their microsomal metabolites, taking into account that QM1 was too chemically unstable and that metabolites AA1, AA2, and AA3 were obtained in quantities insufficient to permit the determination of IC 50 values. 
CP3a
2.7 ± 0.1
a Values are the mean ± SD of two independent experiments.
The antiproliferative activities of freshly synthesized QMs were lower than those of their parent compounds; however, they are quite remarkable if one takes into account their high reactivity in the medium used for measurement of their antiproliferative activity, and the presumably small amounts that could reach the important cell target(s) in our assay conditions. Their contribution to the antiproliferative effects of FCs should be more pronounced in vivo, as they should be produced inside the cell, in the endoplasmic reticulum, close to the key cell targets.
The CP metabolites, which are much more stable in the medium, exhibited lower activities, with IC 50 values 4-to 11-fold higher than that of the parent compound (Table 3) .
This suggests that they would not play a major role in the antiproliferative properties of the corresponding ferrociphenols. Interestingly, primary alcohol PA1, which was obtained by Ten of those FC metabolites were synthesized, and their cytotoxic activities toward hormone-independent breast cancer cells were compared with those of the parent compounds. Then, the mixture was filtered over a 1 cm stick pad of silica gel. The compound was extracted from silica gel by washing with acetone/Et3N (9:1). After solvent evaporation, the crude product was purified by short silica gel column, using acetone/Et3N (9:1) 
2-Ferrocenyl-1-methyl-3-(p-(3-(dimethylamino)propoxy)phenyl)-1H-inden-6-ol (CP3a) and 2-ferrocenyl-1-methyl-3-(p-hydroxy-phenyl)-6-(dimethylamino)propoxy)-1H-indene
Incubations of FCs with liver microsomes:
Microsomes (2 nmol P450 mg protein) were prepared from the livers of rats pretreated with phenobarbital (1 g per liter of drinking water for 7 days) as described previously. 44 Human liver microsomes and insect cell microsomes expressing recombinant human cytochromes P450 were obtained from BD-Gentest (Le Pont de Claix, France). Cytochrome P450 was assayed by the method of Omura and Sato. 45 Proteins were measured according to the method of Lowry et al. using bovine serum albumin as standard. 46 Typical incubations were performed in potassium phosphate buffer (0.1 m, pH 7.4) Figure S11. 13 
